Notably, one PDT line derived from a primary tumor with APC and atypical KRASQ22K mutation, but with intact TGF‐β signaling, displayed enhanced invasive properties, with phenotypic and molecular changes suggestive of partial EMT following TGF‐β1 exposure. This evidence concerns the gene TGFB1 and neoplasm.